title: Challenge-based pregabalin induced urticaria and angioedema. A case report.
authors.forename: M A
authors.initials: MA
authors.lastname: Ortega-Camarero
authors.forename: R
authors.initials: R
authors.lastname: Avila
authors.forename: M
authors.initials: M
authors.lastname: Prados Castaño
authors.forename: M
authors.initials: M
authors.lastname: Piñero
authors.forename: J
authors.initials: J
authors.lastname: Quiralte
authors.forename: S
authors.initials: S
authors.lastname: Cimbollek
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000799:Angioedema / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D059350:Chronic Pain / Q000150:complications / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D007114:Immunization / Q000379:methods; D000069583:Pregabalin; D009435:Synaptic Transmission / Q000187:drug effects; D014581:Urticaria / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000927:Anticonvulsants; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid